Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Higuchi, N. Harada, Y. Sekiya (Kiyose, Japan). Effects of shaking methods of blood collection tubes on QuantiFERON®-TB Gold In-Tube assays. Eur Respir J 2010; 36: Suppl. 54, 3054

Member's Comments

No comment yet.

Related content which might interest you: Necessity of re-centrifugation of QuantiFERON®-TB Gold In-Tube samples after plasma harvest Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 First evaluation of QuantiFERON-TB Gold Plus performance in contact screening Source: Eur Respir J 2016; 48: 1411-1419 Year: 2016 Evaluation of QuantiFERON microtube, using 0.9 mL blood, for diagnosing tuberculosis infection Source: Eur Respir J 2013; 41: 909-916 Year: 2013 Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 Short-term reproducibility of the QuantiFERON-TB gold in-tube assay Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 QuantiFERON-TB® Gold Plus as a potential tuberculosis treatment monitoring tool Source: Eur Respir J , 49 (3) 1601976; DOI: 10.1183/13993003.01976-2016 Year: 2017 Discordance between the QuantiFERON-TB Gold In-Tube and Tuberculin Skin Test: need for a further step? Source: Eur Respir J 2015; 46: 1506-1509 Year: 2015 Using QuantiFERON-TB gold in-tube in contact tracing procedures Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 The influence of a high negative control on the interpretation of QuantiFERON Gold in Tube (QFN) results Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 Effects of corticosteroid treatment on the performance of QuantiFERON Gold In-Tube test in the diagnosis of latent tuberculosis infection Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis Year: 2010 Monitoring the efficacy of anti-TB therapy by using the QuantiFERON-TB Gold in tube test Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 Monitoring the efficacy of anti-TB therapy by using the QuantiFERON-TB Gold In tube test Source: Eur Respir Rev 2008; 17: 74-75 Year: 2008 A comparison of QuantiFERON-TB Gold In-Tube test and new QuantiFERON-Microtube assay in children suspect of active TB and adults with active TB Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 The QuantiFERON-TB Gold test at HIV patients Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010 Evaluation of usefulness of QuantiFERON®-TB Gold for infants Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 First independent evaluation of QuantiFERON-TB Plus performance Source: Eur Respir J 2016; 47:1587-1590 Year: 2016 Programmatic experience with QuantiFERON-TB gold in-tube assay for contact screening in congregate settings in Singapore Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 QuantiFERON-TB gold in tube method in sarcoidosis patients Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis Year: 2009 Preliminary data on precision of QuantiFERON-TB Plus performance Source: Eur Respir J 2016; 48: 955-956 Year: 2016 Preliminary data on precision of QuantiFERON-TB Plus performance Source: Eur Respir J 2016; 48: 953-954 Year: 2016